<DOC>
	<DOCNO>NCT02414035</DOCNO>
	<brief_summary>The purpose study determine whether dabigatran associate high risk bleed Asia area especially China clinical practice whether need set monitor system .</brief_summary>
	<brief_title>Monitor System Safety Dabigatran Treatment</brief_title>
	<detailed_description>Dabigatran administer fix without laboratory monitoring compare warfarin ( international normalize ratio , hundred evidence Asia event several multicenter , prospective , randomize trail . It remain unclear whether Dabigatran safety China clinical practice need monitor test . We identify participant diagnose nonvalved atrial fibrillation , initiate dabigatran diagnosis.We follow individual first prescription dabigatran discontinue use switch anticoagulant , death , outcomes one year later . We categorize bleed event major minor event accord anatomical position . We define time bleed day first dabigatran prescription date bleeding event . We analyze time first bleed event , well time first major hemorrhage , intracranial hemorrhage , gastrointestinal bleeding , hematuria , vaginal bleeding , hemarthrosis , hemoptysis , epistaxis .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>1 . Age &gt; 18 entry 2 . AF document follow : The patient symptomatic episode paroxysmal persistent AF document 12lead ECG , rhythm strip , pacemaker/implantable cardioverterdefibrillator electrogram , Holter ECG 3 . In addition document AF , patient must ≥1 CHADS2VAS score 4 . We identify participant diagnosed AF , initiate dabigatran diagnosis 5 . Written , inform consent 1 . History heart valve disorder ( ie , prosthetic valve hemodynamically relevant valve disease ) 2 . Severe , disable stroke , stroke within previous 14d 3 . Acute coronary syndrome within 1 year AF patient 4 . Conditions associate increase risk bleed 1 . Major surgery previous month 2 . History intracranial , intraocular , spinal , retroperitoneal atraumatic intraarticular bleed 3 . Gastrointestinal hemorrhage hematuria 5 . Severe renal impairment ( estimate creatinine clearace≤30ml/min ) 6 . Severe liver dysfunction 7 . Alcohol abuse drug addiction 8 . Patients receive investigational drug time 9 . Patients consider unreliable investigator life expectancy less expected duration trail</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>Dabigatran</keyword>
</DOC>